Search
Twitter-square Facebook-square Linkedin Youtube

Proactiveinvestors Interviews Bob Proulx

Proactiveinvestors Interviews Bob Proulx

Proactiveinvestors news media have interviewed Imagion Biosystems CEO Bob Proulx, who answers questions about the company’s early cancer detection technology, its place in the the medical imaging market, intellectual property protections, and more.

Imagion Biosytems Pioneering Medical Imaging with “Printer and Ink” Business Model

Related Articles

Successful Placement of A$3M

October 10, 2024

Imagion Biosystems (ASX: IBX) (Company), is pleased to announce the Company has received $3 million of firm commitments through a highly successful capital raising. The

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.

Get in touch

About Imagion Biosystems

Imagion Biosystems (IBX) is an innovative medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases.

Contact us

  • info@imagionbio.com
  • Imagion Biosystems, Ltd. Suite 2, Level 11, 385 Bourke Street, Melbourne VIC 3000, Australia
  • AU +61 3 9692 7222
  • Imagion Biosystems, Inc. PO Box 4410 Incline Village, NV 89450 United States

Join our email list

Stay informed about our latest news and developments.

© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance

Twitter-square Facebook-square Linkedin Youtube